Once-daily glycopyrronium via the Breezhaler® device for the treatment of COPD: pharmacological and clinical profile. [electronic resource]
Producer: 20140502Description: 503-17 p. digitalISSN:- 1751-2441
- Administration, Inhalation
- Animals
- Clinical Trials as Topic
- Drug Administration Schedule
- Dry Powder Inhalers
- Glycopyrrolate -- administration & dosage
- Humans
- Molecular Structure
- Muscarinic Antagonists -- administration & dosage
- Pulmonary Disease, Chronic Obstructive -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.